Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
13.72
+0.10 (0.73%)
At close: May 7, 2026, 4:00 PM EDT
13.85
+0.13 (0.95%)
After-hours: May 7, 2026, 6:54 PM EDT
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,700 employees as of December 31, 2025. The number of employees increased by 400 or 4.82% compared to the previous year.
Employees
8,700
Change (1Y)
400
Growth (1Y)
4.82%
Revenue / Employee
$350,099
Profits / Employee
$14,037
Market Cap
4.38B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8,700 | 400 | 4.82% |
| Dec 31, 2024 | 8,300 | 450 | 5.73% |
| Dec 31, 2023 | 7,850 | 250 | 3.29% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 1,000 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| HUTCHMED (China) | 1,796 |
| Lantheus Holdings | 1,193 |
| ANI Pharmaceuticals | 970 |
| Supernus Pharmaceuticals | 778 |
| Prestige Consumer Healthcare | 600 |
AMRX News
- 9 hours ago - Amneal Pharmaceuticals reports Q1 EPS 27c, consensus 17c - TheFly
- 10 hours ago - Amneal Pharmaceuticals backs FY26 adjusted EPS view 95c-$1.05, consensus $1.00 - TheFly
- 11 hours ago - Amneal Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 1 day ago - Amneal Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 15 days ago - Amneal Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 15 days ago - Amneal Pharma to buy Kashiv BioSciences in $1.1 billion deal - Reuters
- 15 days ago - Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader - Business Wire
- 15 days ago - Amneal Pharmaceuticals raises FY26 adjusted EPS view to 95c-$1.05 from 93c-$1.03 - TheFly